Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 22;12(13):4213.
doi: 10.3390/jcm12134213.

Assessing the Novel Myval Balloon-Expandable Valve with the Evolut Valve: A Propensity-Matched Study

Jonathan Halim  1 , Maxim Rooijakkers  2 , Peter den Heijer  1 , Milad El Haddad  3 , Ben van den Branden  1 , Jeroen Vos  1 , Bas Schölzel  1 , Martijn Meuwissen  1 , Menno van Gameren  1 , Saloua El Messaoudi  2 , Niels van Royen  2 , Sander IJsselmuiden  1
Affiliations

Assessing the Novel Myval Balloon-Expandable Valve with the Evolut Valve: A Propensity-Matched Study

Jonathan Halim et al. J Clin Med. .

Abstract

Background: The Myval balloon-expandable (BE) valve has shown encouraging early clinical data in terms of safety and efficacy. Comparative data with other well-established contemporary valves are nonetheless still scarce. This study aims to compare the performance of the Myval BE valve with the Evolut self-expanding (SE) valve.

Methods: In this retrospective single-center study, 223 patients with symptomatic severe aortic stenosis (AS) were included and treated with the Myval BE valve (n = 120) or with the Evolut SE valve (n = 103). Then, 91 pairs were compared after matching. Clinical outcomes were evaluated at 30 days and 1 year. Echocardiographic follow-up was performed at 30 days.

Results: Procedural complications were rare in both groups. At the 30-day follow-up, no significant difference in cardiac death (Myval: 1% vs. Evolut: 2%, p = 0.56), stroke (2% vs. 4%, p = 0.41) and myocardial infarction (1% vs. 3%, p = 0.31) was observed. A permanent pacemaker implantation (PPI) was significantly less needed in the Myval group (4% vs. 15%, p = 0.01). At 1 year, cardiac death (2% vs. 4%, p = 0.41) and the stroke rate (7% vs. 5%, p = 0.76) were similar. Moderate-severe paravalvular leakage (PVL) was also comparable in both groups (1% vs. 4%, p = 0.17).

Conclusion: Safety and efficacy outcomes were comparable between the two valves, except for a higher PPI rate for the Evolut SE valve. Up to 1-year follow-up, clinical outcomes showed acceptable rates of stroke and cardiac death with both valves. Valve hemodynamics were excellent with a low rate of moderate-severe PVL in both groups.

Keywords: aortic valve stenosis; myval valve; transcatheter aortic valve replacement.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PPI rate at 30 days. Abbreviation: PPI = Permanent pacemaker implantation.
Figure 2
Figure 2
Distribution of the degree of PVL at 30 days. Abbreviation: PVL= Paravalvular leakage.
Figure 3
Figure 3
Aortic valve mean gradient at baseline compared to 30-day follow-up.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Cribier A.G. The Odyssey of TAVR from concept to clinical reality. Tex. Heart Inst. J. 2014;41:125–130. doi: 10.14503/THIJ-14-4137. - DOI - PMC - PubMed
    1. Bourantas C.V., Serruys P.W. Evolution of transcatheter aortic valve replacement. Circ. Res. 2014;114:1037–1051. doi: 10.1161/CIRCRESAHA.114.302292. - DOI - PubMed
    1. Pilgrim T., Lee J.K., O’Sullivan C.J., Stortecky S., Ariotti S., Franzone A., Lanz J., Heg D., Asami M., Praz F., et al. Early versus newer generation devices for transcatheter aortic valve implantation in routine clinical practice: A propensity score matched analysis. Open Heart. 2018;5:e000695. doi: 10.1136/openhrt-2017-000695. - DOI - PMC - PubMed
    1. Stundl A., Lucht H., Shamekhi J., Weber M., Sedaghat A., Mellert F., Grube E., Nickenig G., Werner N., Sinning J.M. Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index) PLoS ONE. 2019;14:e0217544. doi: 10.1371/journal.pone.0217544. - DOI - PMC - PubMed
    1. Yoon S.-H., Lefevre T., Ahn J.-M., Perlman G.Y., Dvir D., Latib A., Barbanti M., Deuschl F., De Backer O., Blanke P., et al. Transcatheter aortic valve replacement with early-and new-generation devices in bicuspid aortic valve stenosis. J. Am. Coll. Cardiol. 2016;68:1195–1205. doi: 10.1016/j.jacc.2016.06.041. - DOI - PubMed